Levine LS. Congenital adrenal hyperplasia. Pediatr Rev. 2000;21(5):159–71.
Article CAS PubMed Google Scholar
El-Maouche D, Arlt W, Merke DP. Congenital adrenal hyperplasia. Lancet. 2017;390(10108):2194–210.
Article CAS PubMed Google Scholar
Krone N, Dhir V, Ivison HE, Arlt W. Congenital adrenal hyperplasia and P450 oxidoreductase deficiency. Clin Endocrinol. 2007;66(2):162–72.
Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95(9):4133–60.
Article CAS PubMed PubMed Central Google Scholar
van der Kamp HJ, Wit JM. Neonatal screening for congenital adrenal hyperplasia. Eur J Endocrinol. 2004;151(Supplement3):U71–5.
Pang S, Shook MK. Current status of neonatal screening for congenital adrenal hyperplasia. Curr Opin Pediatr. 1997;9(4):419–23.
Article CAS PubMed Google Scholar
García GM, de la Rosa IG, Reyes EC, Torres AR, Guerra JM, Marín MH, et al. Generation of monoclonal antibodies against 17α-hydroxyprogesterone for newborn screening of congenital adrenal hyperplasia. Clin Chim Acta. 2018;485:311–5.
Nah EH, Cho S, Kim S, Cho HI, Stingu CS, Eschrich K, et al. International organization for standardization (ISO) 15189. Ann Lab Med. 2017;37(5):365–70.
Topic E, Nikolac N, Panteghini M, Theodorsson E, Salvagno GL, Miler M, et al. How to assess the quality of your analytical method? Clin Chem Lab Med. 2015;53(11):1707–18.
Article CAS PubMed Google Scholar
Antonelli G, Sciacovelli L, Aita A, Bozzato D, Plebani M. The pathway for introducing novel examination procedures in routine practice in accordance with ISO 15189: 2012: 17-Hydroxy progesterone, dehydroepiandrosterone sulphate and vitamin D as examples. Ann Clin Biochem. 2019;56(5):548–55.
Article CAS PubMed Google Scholar
Debeljak Ž, Marković I, Pavela J, Lukić I, Mandić D, Mandić S, et al. Analytical bias of automated immunoassays for six serum steroid hormones assessed by LC-MS/MS. Biochem Med. 2020;30(3):422–31.
Taylor AE, Keevil B, Huhtaniemi IT. Mass spectrometry and immunoassay: how to measure steroid hormones today and tomorrow. Eur J Endocrinol. 2015;173(2):D1–2.
Article CAS PubMed Google Scholar
Alhajj M, Zubair M, Farhana A. Enzyme linked immunosorbent assay. StatPearls. 2023.
Sakamoto S, Putalun W, Vimolmangkang S, Phoolcharoen W, Shoyama Y, Tanaka H, et al. Enzyme-linked immunosorbent assay for the quantitative/qualitative analysis of plant secondary metabolites. J Nat Med. 2018;72:32–42.
Article CAS PubMed Google Scholar
Cinquanta L, Fontana DE, Bizzaro N. Chemiluminescent immunoassay technology: what does it change in autoantibody detection? Auto Immun Highlights. 2017;8:1–8.
EP15 A3. User Verification of Precision & Bias Estimation [Internet]. [cited 2024 Jul 23]. https://clsi.org/standards/products/method-evaluation/documents/ep15/
Tsai WH, Wong CH, Dai SH, Tsai CH, Zeng YH. Adrenal tumor mimicking non-classic congenital adrenal hyperplasia. Front Endocrinol. 2020;11:526287.
Trapp CM, Speiser PW, Oberfield SE. Congenital adrenal hyperplasia: an update in children. Curr Opin Endocrinol Diabetes Obes. 2011;18(3):166–70.
Article CAS PubMed PubMed Central Google Scholar
Dou X, Wang E, Hu J, Zong Z, Jiang R, Wang M, et al. Comparison of three automatic chemiluminescent immunoassays for monitoring dynamic profile of SARS-CoV‐2 IgG and IgM. J Clin Lab Anal. 2021;35(1):e23681.
留言 (0)